Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent










































Aging is characterized by progressive
  decline in the 
efficiency of physiological functions, resulting in an 
increased vulnerability of organisms to environmental 
stressors and in a growing risk of disease and death [1]. 
One of the most striking changes that occur during 
normal human aging is immunosenescence, a pro-
gressive and generalized deterioration of immune 
functions that affects all cells and organs of the innate 
and adaptive immune systems. Progressive involution 
of the thymus, a hallmark of aging, leads to a decline of 
those immune functions that are related  to T cell-depen- 
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dent immunity and are generally associated with an 
increase in susceptibility to infections as well as 
increased incidence of autoimmune phenomena and 
cancer in the elderly [2,3]. The mechanism that 
underlines involution of the thymus is not well 
understood. Elucidation of such mechanisms is required 
to find a rational therapy that can prevent (or even 
reverse) lowering immunity in aged individuals [4,5]. 
Such a strategy will be in line with manifesto of 
Blagosklonny, Campisi and Sinclair published in the 
first issue of this journal [6]. 
 
There are several potential therapeutic approaches now  
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antioxidant treatment, which has been shown to be 
beneficial for immune cell function in the elderly [7, 8]. 
Since Harman (1956) [9], who formulated the free 
radical theory of aging, antioxidants have been studied 
as anti-aging drugs in many laboratories. Fast 
senescence-prone animals suffering from oxidative 
stress are often a subject of such studies. One of these 
models, namely OXYS rats, was elaborated in our 
group. OXYS rats show significantly shortened lifespan 
(maximal lifespan is 28% shorter than that of Wistar 
rats) and early development of age-associated patho-
logical phenotypes similar to several age-linked 
disorders observed in humans, including cataract, 
retinopathies, senile osteoporosis, high blood pressure, 
and higher levels of oxidative damage to lipids and 
proteins. Behavior of rather young OXYS rats is similar 
to the behavior of old Wistar rats and can be improved by 
treatment with antioxidants [10-14]. A premature invo-
lution of the thymus and a decline of function of T cell-
dependent immunity is inherent in OXYS rats [15, 16].  
 
Mitochondrial dysfunctions increasing with age are 
thought to be a causal factor for accelerated senescence 
in OXYS rats [16-19]. If this were the case, antioxidants 
might delay senescence in OXYS rats. Some indications 
supporting this has already been published [12,20]. 
Recently, we showed that nanomolar amounts of 
mitochondria-targeted antioxidant SkQ1 (plastoquino-
nyl decyltriphenyl phosphonium) are capable of 
preventing some consequences of accelerated sense-
cence in OXYS rats. One of the important advantages of 
SkQ1 is its rapid reduction by the mitochondrial 
respiratory chain complex III, i.e. SkQ1 is a rechargeable 
antioxidant [21]. According to our data, addition of very 
small amounts of SkQ1 to food completely prevented 
development of cataract and retinopathies in OXYS rats 
up to the age of two years [13]. The aim of the present 
study was to examine whether SkQ1 affects fast 




Thymic involution in Wistar and OXYS rats at 
different ages 
 
The thymus of OXYS rats, like that of Wistar rats, 
consists of two lobes of unequal size, which are tightly 
juxtaposed and separated by a thin layer of loose 
connective tissue. The anatomy of the thymus of OXYS 
and Wistar rats seem to be similar. However, 
microscopic studies of serial sections of OXYS rat 
thymus at 10 days of age revealed immature lobules 
which were remarkable for their lack of distinct 
differentiation between cortex and medulla as well as 
low cell density. 
 
The absolute weight of the thymus in OXYS rats is 
significantly lower than in Wistar rats (Figure 1). This is 
partially due to smaller body weight of OXYS rats. 
However, at age 2 and 3.5 months, not only absolute 
thymic weight but also thymic weight normalized to the 
body weight (thymic index) of OXYS rats was shown to 
be lower than that of Wistar rats (Figure 1B).  
 
The total volume of the thymus significantly increased 
in both rat strains from age 10 days to age 2 months, 
reached a maximum, and then declined slightly between 
2 and 3.5 months of age and significantly between 3.5 
and 14 months of age. The total volume was always 
lower in OXYS rats, and the difference was statistically 
significant at age 10 days and 2 and 14 months (Figure 
1C).  
 
The thymic cortex volume in both strains of rats 
increased between 10 days and 2 months of age, 
reached a maximum, and then decreased (Figure 1D). 
At all time points, the thymic cortex volume was lower 
in OXYS rats, and statistically significant differences 
were observed at age 10 days and 2 and 14 months. 
 
The volume of the medulla also increased in both 
strains of rats between 10 days and 2 months of age, 
reached a maximum at 3.5 months, and then declined 
(Figure 1E). The medulla volume was always lower in 
OXYS rats. 
 
The ratio of cortex to medulla (C/M index) changed 
with age in a fashion similar in the two studied rat 
strains (not shown in figures). 
 
The volume of connective tissue stroma of the thymus, 
the capsule, and septa changed as a function of age of 
the animals. It increased significantly between 10 days 
and 2 months of age, did not noticeably change between 
2 and 3.5 months, and declined by 14 months in both rat 
strains. At all time points, the absolute value was lower 
in OXYS rats due to lower total thymic size (not 
shown).  
 
One of the characteristic signs of age-related involution 
of the thymus is replacement of lymphoid tissue with 
adipose tissue. In the thymuses of 10-day-old Wistar 
and OXYS rats, adipose tissue was not detectable. At 
age 2 and 3.5 months, single adipocytes were 
observable in the capsule and septa. At age 14 months, 
adipose tissue occupied measurable part of the thymus. 
This volume was two-fold higher in Wistar rats 
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adipose tissue in the thymus of OXYS and Wistar rats 































































   























































































































   


















































































































   
www.impactaging.com                  393                                     AGING, April 2009, Vol.1 No.4At age 10 days and 2 and 3.5 months, the total number 
of cells (cellularity) in the thymus and immunological 
phenotype of thymocytes was determined using flow 
cytometry. Major subpopulations of thymocytes were 
detected by means of surface markers for CD3+, CD4+, 
and CD8+ cells. Two-way ANOVA analysis showed 
that the total cell number in the thymus changed with 
age. In both strains, it increased between 10 days and 2 
months, reached a maximum, and then declined. No 
strain difference in total cell number was found on day 
10. At the age of 2 and 3.5 months, this parameter was 
lower in OXYS than in Wistar rats (Figure 1F). Double-
positive lymphocytes were the predominant cell type in 
the thymus at all time points in both strains. Their 
relative number was the highest in 10-day-old animals 
regardless of the strain. This measure tended to decrease 
with age (not shown).  
 
The second most numerous subpopulation among 
thymocytes was mature CD4+ lymphocytes (Т-helper 
cells). Their number was not significantly different 
between the rat strains, but changed with age. The 
percentage of CD4+ cells was the lowest on day 10 in 
both rat strains, increased at age 2 months and 
decreased at age 3.5 months (Table 1).  
 
The third most numerous subpopulation of thymocytes 
was CD8+ cells (cytotoxic T lymphocytes and 
suppressor T cells). Their dynamics were similar to that 
of CD4+ cells (Table 1). The relative number of all 
CD3+ thymocytes was dependent on both genotype and 
age of the animals. This parameter lowered with age in 
both rat strains, the lowering being stronger in the 
OXYS rats (Table 1). Analysis of subfractions of CD3+ 
cells showed that the content of CD3+
low+med cells was 
lower in OXYS rats compared to Wistar rats (not 
shown). As to CD3+
hi, it first increased and then 
decreased with age in both strains of rats (Table 1). 
 
An important parameter of a population of single-
positive thymocytes is the CD4+/CD8+ ratio. In the 
present study, it decreased with age in both strains 
(Table 1).  
 
These results indicate that both OXYS and Wistar rats 
exhibit age-dependent signs of primary hypoplasia of 
the thymus, as evidenced by the lowering of average 
thymic weight and total volume, decrease in volumes of 
cortex and medulla (epithelial compartment of the 
thymus), as well as total numbers of thymic cells, and 
lowering of absolute numbers of major subpopulations 
of thymocytes. The direction of all these changes was 
similar in two strains. However, by the end of fast body 
growth and the beginning of age-related thymic invo-
lution (age 2 to 3.5 months), lowering of the thymic 
cellularity developed more quickly in OXYS rats.  
 
Effect of mitochondria-targeted antioxidant SkQ1 
on thymic characteristics of OXYS and Wistar rats  
 
In the second part of the investigation, we studied the 
effect of SkQ1 on the morphological and functional 
state of the thymus of Wistar and OXYS rats. The 
animals received the drug with food at the dose of 250 
nmol SkQ1/kg body per day weight from the age of 1.5 
to 14 months.  
 
Two-factorial dispersion analysis of weight 
measurements at age 3.5 months revealed that the drug 
treatment increases the absolute weight of the thymus 
(not shown) and thymic weight index (Figure 2A). In 
OXYS rats, the increase was stronger, being statistically 
significant. Similar relationships were revealed when 
the total thymic volume was measured (Figure 2B). The 
SkQ1 treatment also enhanced the volumes of structural 
components of the thymus – cortex, medulla, and 
connective tissue stroma. Again, the effect (a volume 
increase) was stronger in OXYS rats (Figure 2C-E).  
 
The total number of cells in the thymus was affected by 
both drug treatment and genotype of the animals. The 
thymic cellularity in OXYS rats was much lower than in 
Wistar rats and was increased threefold by the SkQ1 
treatment (Figure 2F).  
 
Data on amounts of various cell fractions in the thymus 
of Wistar and OXYS rats treated and non-treated with 
SkQ1 are shown in Table 2. The table shows that 
percentage content of various subpopulations of thymo-
cytes did not undergo significant changes as a result of 
the SkQ1 treatment. However, the analysis of absolute 
values revealed very strong positive effect of SkQ1. 
 
Cell cycle analysis in thymocytes did not show 
significant differences between OXYS and Wistar rats. 
SkQ1 also had no effect on the percentage of cells in 
various phases of the cell cycle. The percentage of cells 
with fragmented DNA, characteristic of apoptosis (<G0), 
tended to be higher in OXYS rats and was lowered 
somewhat with the drug treatment, but these changes 
were not statistically significant (data not shown). 
 
The number of thymocytes at the various stages of 
apoptosis was determined using parallel staining of the 
tissue from 3.5 months rats with annexin V, 7-amino-
actinomycin D (7-ААD), or TUNEL followed by flow 
cytometry. No significant effects of strain or SkQ1 were 
revealed (not shown).  
 
   





























































































Figure  2B.  Effect  of  SkQ1  on  thymic




















Figure  2C.  Effect  of  SkQ1  on  thymic





   








































































Figure  2D.  Effect  of  SkQ1  on  thymic




















Figure  2E.  Effect  of  SkQ1  on  thymic
involution  in  Wistar  and  OXYS  rats.



















Figure  2F.  Effect  of  SkQ1  on  thymic
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studied on old (14 months) Wistar and OXYS rats. The 
data are summarized in Table 3. One can see pro-
nounced SkQ1-induced increase in the thymic weight 



















































and medulla. Volumes of thymic stroma and adipose 
tissue slightly or strongly increased, respectively. All the 
above changes with the exception of the adipose tissue 
volume were larger in Wistar than in OXYS rats (in con-


















































   



































Age-dependent involution of the thymus is one of the 
best examples of programmed senescence [22-24]. It is 
clearly under control of genetic mechanisms responsible 
for ontogenesis, like, e.g., programmed involution of 
gills or tail in human embryo. The only difference 
between gills (or tail) involution and that of thymus 
consists in that they occur in the pre- and postnatal 
periods, respectively. In rats, absolute weight of thymus 
is maximal in 2-month-old animals and then strongly 
lowers with age down to 10-15% of maximal value at 
14 months (Figure 1A). Such an involution is known to 
be species-specific, being much slower in long-lived 
than in short-lived organisms. This rule is also valid for 
strains of one and the same species. In our case, the 
thymic weight index of short-lived OXYS rats was 







































but then decreased with age faster than that of Wistar 
rats (Figure 1B). 
 
There are several pieces of evidence indicating that 
intramitochondrial ROS are necessary intermediates of 
the senescence program (for reviews, see [16, 22, 23]). 
This is why in our group a mitochondria-targeted 
rechargeable antioxidant SkQ1 was synthesized and 
tested as a potential geroprotector [16, 25-28]. It was 
found that SkQ1 prolongs lifespan of different species: 
from podospora (a fungus) to mouse. In mouse, 
development of numerous traits of senescence were 
decelerated or stopped (in certain cases, even reversed) 
by very small amounts of SkQ1 [16, 26]. In particular, it 
was found that SkQ1-treated mice kept in a non-sterile 
vivarium were resistant to various infections causing 
death of the non-treated control animals [16, 26]. This 
effect was mainly responsible for a two-fold increase in 
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hypothesized that age-dependent decline of the immune 
system, being a part of the senescence program, is 
decelerated by SkQ1. Because thymic involution is one 
of the most important constituents of the decline of 
immune system with age, it was interesting to study the 
effect of SkQ1 upon this process. 
 
Experiments were performed on a normal (Wistar) and 
a fast senescence-prone (OXYS) rat strains, the latter 
suffering from constant oxidative stress. In OXYS rats, 
involution of the thymus was shown to occur faster than 
in Wistar rats (Figure 1, Table 1).  
 
As to SkQ1, it decreased the rate of thymic involution 
in both studied strains, the drug action being more 
pronounced in OXYS rats at age 3.5 months and in 
Wistar rats at age 14 months. Small amounts of SkQ1 
(250 nmol/kg per day with food) were found to strongly 
decrease such parameters of thymic involution as 
lowering of (i) absolute thymic weight, (ii) thymic 
weight index, (iii) total volume of thymus, (iv) volume 
of thymic cortex, (v) volume of thymic medulla, (vi) 
thymic cellularity, (vi) absolute amounts of the CD3+, 
CD4+, and CD8+ cells in the thymus, relative amount 
(percentage) of each cell type being unaffected (Figure 
2 and Tables 2,3). These results are consistent with our 
suggestion that SkQ1 interferes with execution of a 
senescence program responsible, in particular, for age-






In our experiments, we used males of OXYS rats at 10 
days and 2, 3.5, and 14 months of age as well as age-
matched male Wistar rats. The OXYS strain of rats was 
developed at the Institute of Cytology and Genetics, 
Siberian Division of the Russian Academy of Sciences, 
from Wistar stock by selection for their susceptibility to 
the cataractogenic effect of galactose [29]. To attain this 
goal, young Wistar rats were fed galactose-rich diets, 
and animals highly susceptible to the cataractogenic 
effect of those diets were selected for inbreeding. After 
five cycles of inbreeding, the subsequent generations of 
rats developed cataracts spontaneously, i.e. without 
galactose supplementation of the diet. This rat strain 
was called by the International Rat Genetic 
Nomenclature Committee as the OXYS rat strain [30]. 
At present, the strain of OXYS rats is maintained in the 
Breeding Experimental Animal Laboratory of the 
Institute of Cytology and Genetics. 
 
The animals were housed in cages (45×35×35 cm) and  
kept under standard laboratory conditions (at 22 ± 1º C, 
60% relative humidity, natural light), provided with a 
standard rodent diet (PK-120-1, Ltd. ‘Laboratorsnab’, 
Russia) ad libitum. OXYS rats of all age groups had 
lower body weight compared to Wistar rats (21 ± 2 and 
16 ± 1 g at day 10 (p < 0.007), 212 ± 5, and 247 ± 8 g at 
2 months (p < 0.002), 307 ± 10 and 403 ± 11 g at 3.5 
months (p < 0.001), and 404 ± 6 and 628 ± 29 g (p < 
0.001) at 14 months of age, respectively. 
 
The thymus was examined histopathologically and by 
morphometry. The cellular content of the thymus and 
immunologic phenotype of thymic cells were measured 
by flow cytometry. 
 
To determine the effects of long-term dietary SkQ1 
supplementation on the thymus of the experimental 
animals, we started with 1.5-month-old males of OXYS 
and Wistar rat strains. The rats were randomly assigned 
to one of two groups: a control diet and diet 
supplemented with SkQ1 (250 nmol/kg of body mass 
per day). The latter group received SkQ1 up to the age 
of 14 months. 
 
All the experiments on rats were carried out in line with 
Animal Care Regulations of Institute of Cytology and 
Genetics, Novosibirsk.  
 
Histology and morphometric characteristics 
 
The thymus was weighed to estimate the weight index 
(mg thymus/100 g body weight), fixed in Telesnitsky 
fixative at 4°C, dehydrated in alcohols of increasing 
grade, cleared in xylene, and embedded in Paraplast 
Plus. Serial frontal sections were cut at 5 μm and 
stained with hematoxylin and eosin. Each 60
th section 
was examined by light microscopy. Morphometry of 
structural components of the thymus was carried out by 
stereologic techniques and the absolute total thymic 





Thymic cellularity and immunologic phenotype.  The 
thymus was placed in RPMI-1640 medium with 2% 
fetal calf serum and 1% sodium azide. Single-cell 
suspension of thymocytes was prepared and the total 
number of thymocytes was determined. A 100-μl 
aliquot of the cell suspension was incubated with a 
fluorochrome-conjugated antibody at room temperature 
for 15 min. The following monoclonal antibodies (all 
from BD Pharmingen, San Diego, Calif., USA) were 
used for staining: FITC-conjugated anti-CD3 (Cat. No. 
559975), PE-conjugated anti-CD4 (Cat. No. 551397), 
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After staining, the cells were washed twice with PBS 
containing 0.1% sodium azide and fixed in PBS with 
1% formaldehyde. The samples were analyzed by flow 
cytometry on the FACS Calibur instrument (Becton 
Dickinson, USA) using Cell Quest computer software. 
 
Analysis of apoptosis.  The frequency of apoptosis 
was estimated by flow cytometry using an annexin V-
PE apoptosis detection Kit I (BD Pharmingen, Cat. No. 
559763) and an APO-BrdU Kit (BD Pharmingen, Cat. 
No. 556405) according to the manufacturer’s 
instructions. 
 
Cell cycle analysis. A sample of 10
5 cells was fixed with 
70% ethanol, washed with PBS, incubated for 20 min 
with 0.5 ml propidium iodide solution (10 μg/ml in 
PBS) plus RNase (5 mg/ml) in the dark at room 
temperature. Samples were analyzed by flow cytometry 
on the FACS Calibur instrument using Cell Quest 
computer software. The percentages of cells within 
G0/G1, S, G2/M phases and <G0 were determined. 
 
Statistical analysis.  The data were analyzed using 
ANOVA with the statistical package Statistica 6.0. The 
independent variables were the genotype for 
comparison between OXYS and Wistar rats and the age 
for comparison between 10 days and 2, 3.5, and 14 
months of age. Two-way ANOVA (age×genotype) was 
used to evaluate the differences between Wistar and 
OXYS rats across different ages. To test the effect of 
the SkQ1, the strain and antioxidant were chosen as 
independent variables. A Newman−Keuls post hoc test 
was applied to significant main effects. One-way 
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